What is ViaDerma, Inc. (VDRM)?

ViaDerma, Inc. (VDRM) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of VDRM?

The current price of VDRM is $0.00. Prices are updated in real time on Stocks360.

What is VDRM's price-to-earnings (PE) ratio?

VDRM's trailing twelve-month PE ratio is 28.74, based on current price and earnings per share data available on Stocks360.

What is VDRM's market capitalization?

VDRM's market capitalization is $123,371.00, placing it in the small-cap tier.

ViaDerma, Inc. (VDRM)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$123.37K

PE (TTM)

28.74

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.20

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.01

Avg Volume

N/A

Volume

4.00K

ViaDerma, Inc. (VDRM) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $123.37K. Trailing PE 28.74. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.00 2026-10-29 · $0.00 (+0.00%)

Earnings

Most Recent

Dec 15, 2024

EPS $-0.00 vs est. $1.54

Missed by $1.54

Proprietary Signals

Signal snapshot temporarily unavailable.

About ViaDerma, Inc.

ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Décor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	28.74×
P/S (TTM)	0.21×
P/B	0.96×
P/FCF (TTM)	704.98×
EV / EBITDA	5.40×
EV / Sales	0.73×
Earnings Yield	3.48%
Free Cash Flow Yield	0.14%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$436.07K
Revenue (TTM)	$600.50K
Net Income (TTM)	$4.29K
Free Cash Flow (TTM)	$76.59K
Net Debt	$312.70K
Working Capital	$121.18K
Gross Margin	99.97%
Operating Margin	30.85%
Net Margin	0.68%
Return on Equity	-0.48%
Return on Invested Capital	41.53%